Stryker Co. (NYSE:SYK) Shares Sold by William Blair Investment Management LLC


Share on StockTwits

William Blair Investment Management LLC lowered its holdings in shares of Stryker Co. (NYSE:SYK) by 5.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 319,729 shares of the medical technology company’s stock after selling 18,540 shares during the period. William Blair Investment Management LLC owned about 0.09% of Stryker worth $78,346,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Slow Capital Inc. acquired a new position in Stryker during the third quarter worth about $27,000. Fortis Group Advisors LLC acquired a new position in Stryker during the third quarter worth about $30,000. RWM Asset Management LLC purchased a new stake in shares of Stryker during the fourth quarter worth about $33,000. Graves Light Private Wealth Management Inc. purchased a new stake in shares of Stryker during the fourth quarter worth about $41,000. Finally, BNC Wealth Management LLC purchased a new stake in shares of Stryker during the third quarter worth about $42,000. Institutional investors own 71.46% of the company’s stock.

SYK has been the subject of a number of recent research reports. Canaccord Genuity lowered their price target on shares of Stryker from $240.00 to $234.00 and set a “buy” rating for the company in a report on Friday, October 30th. Robert W. Baird lifted their price target on shares of Stryker from $243.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, November 12th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Stryker from $228.00 to $251.00 and gave the stock a “buy” rating in a report on Thursday, January 28th. Credit Suisse Group lowered their price target on shares of Stryker from $278.00 to $273.00 and set an “outperform” rating for the company in a report on Thursday, January 28th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Stryker in a report on Thursday, January 28th. Three analysts have rated the stock with a sell rating, six have issued a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $227.00.

In other Stryker news, CFO Glenn S. Boehnlein sold 2,000 shares of the stock in a transaction on Monday, December 28th. The shares were sold at an average price of $239.10, for a total transaction of $478,200.00. Following the sale, the chief financial officer now directly owns 14,321 shares of the company’s stock, valued at $3,424,151.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Kevin Lobo sold 10,697 shares of the stock in a transaction on Monday, December 7th. The stock was sold at an average price of $236.28, for a total transaction of $2,527,487.16. The disclosure for this sale can be found here. 6.80% of the stock is currently owned by corporate insiders.

SYK opened at $243.15 on Tuesday. The stock has a market capitalization of $91.47 billion, a PE ratio of 52.74, a P/E/G ratio of 2.79 and a beta of 0.87. The firm’s fifty day moving average price is $240.09 and its 200 day moving average price is $222.33. The company has a debt-to-equity ratio of 0.92, a current ratio of 2.89 and a quick ratio of 2.15. Stryker Co. has a 12-month low of $124.54 and a 12-month high of $248.69.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Tuesday, January 26th. The medical technology company reported $2.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.55 by $0.26. The firm had revenue of $4.26 billion for the quarter, compared to analysts’ expectations of $4.33 billion. Stryker had a net margin of 12.35% and a return on equity of 20.94%. The firm’s quarterly revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the company posted $2.49 earnings per share. On average, equities research analysts forecast that Stryker Co. will post 7.18 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 30th. Shareholders of record on Wednesday, March 31st will be issued a dividend of $0.63 per share. The ex-dividend date of this dividend is Tuesday, March 30th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.04%. Stryker’s dividend payout ratio (DPR) is 30.51%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties.

Featured Story: What is range trading?

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.